APR 2·Simply Wall Street▲
Does Niagen IV Expansion Sharpen OneSpaWorld’s Premium Wellness Edge Or Test Its Focus (OSW)?
OneSpaWorld (OSW) has partnered with Niagen Bioscience to offer pharmaceutical-grade Niagen IV in over 80 Medi-Spa clinics on cruise ships, extending its premium wellness services. This move enhances OSW's appeal to health-conscious passengers and strengthens its position in the high-end onboard wellness market, fitting its strategy of capitalizing on growing wellness spending. Investors should consider that while this expansion and OSW's recent inclusion in S&P indices boost visibility, the company still maintains significant exposure to the cruise sector's inherent risks.
JAN 18·MarketBeat→
Short Interest in OneSpaWorld Holdings Limited (NASDAQ:OSW) Grows By 49.0%
Short interest in OneSpaWorld Holdings Limited (NASDAQ:OSW) increased significantly by 49.0% in December, reaching 2,522,562 shares. This represents approximately 2.6% of the company's shares and results in a short-interest ratio of 5.5 days. Despite a consensus "Buy" rating from analysts with an average price target of $24.80, insiders, including the CEO and a director, sold shares in early December, even as the company raised its quarterly dividend.
